Back to company

REFLAB ApS: Financial statements 2017

CVR: 15322586

REFLAB ApS (CVR 15322586) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,782,613 and a net result of DKK -1,008,355 compared with DKK -1,802,778 the year before. That is an increase of 60.6% compared with the year before. Equity amounted to DKK 668,756. The solvency ratio was 15.6%. The company had 7 employees in the financial year.

Gross Profit
2,782,613 kr.
Profit/Loss
-1,008,355 kr.
Equity
668,756 kr.
Total Assets
4,292,625 kr.
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-2.8 mio.-1 mio.669 t.7
2016-1.7 mio.-1.8 mio.1.7 mio.6
2015-3 mio.-382 t.3.5 mio.-
2014-4.6 mio.1.1 mio.3.9 mio.-
2013-3.7 mio.98 t.2.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like REFLAB ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

REFLAB ApS appoints new auditorDec 20, 2017

As of December 20, 2017, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of REFLAB ApS.

Auditor steps down at REFLAB ApSDec 20, 2017

As of December 20, 2017, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of REFLAB ApS.

REFLAB ApS: The 2016 annual report is outFeb 21, 2017

REFLAB ApS has published its annual report for 2016. Gross profit came to DKK 1,732,908, and the net result was DKK -1,802,778.

About REFLAB ApS

REFLAB ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 1991. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named REFERENCELABORATORIET ApS. The management consists of Gert Pynt Andersen. The company is owned by R-Biopharm AG. The company has 7 employees. In 2025, the company reported a gross profit of DKK 4,582,184 and a net result of DKK -1,792,430 compared with DKK 652,577 the year before. Equity amounted to DKK -635,048.